AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 42.81% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 71.61M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 71.61M.
Fairly Valued
The company’s latest PE is -3.24, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 6.52M shares, decreasing 17.59% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 26.75K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.27.